Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice.
Dunkel J, Viitala M, Karikoski M, Rantakari P, Virtakoivu R, Elima K, Hollmén M, Jalkanen S, Salmi M. Dunkel J, et al. Among authors: viitala m. Front Immunol. 2018 Oct 8;9:2257. doi: 10.3389/fimmu.2018.02257. eCollection 2018. Front Immunol. 2018. PMID: 30349531 Free PMC article.
Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E-/- Mice.
Rinne P, Kadiri JJ, Velasco-Delgado M, Nuutinen S, Viitala M, Hollmén M, Rami M, Savontaus E, Steffens S. Rinne P, et al. Among authors: viitala m. Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):313-323. doi: 10.1161/ATVBAHA.117.310418. Epub 2017 Dec 28. Arterioscler Thromb Vasc Biol. 2018. PMID: 29284608 Free PMC article.
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial.
Virtakoivu R, Rannikko JH, Viitala M, Vaura F, Takeda A, Lönnberg T, Koivunen J, Jaakkola P, Pasanen A, Shetty S, de Jonge MJA, Robbrecht D, Ma YT, Skyttä T, Minchom A, Jalkanen S, Karvonen MK, Mandelin J, Bono P, Hollmén M. Virtakoivu R, et al. Among authors: viitala m. Clin Cancer Res. 2021 Aug 1;27(15):4205-4220. doi: 10.1158/1078-0432.CCR-20-4862. Epub 2021 Jun 2. Clin Cancer Res. 2021. PMID: 34078651 Free PMC article. Clinical Trial.
Preparation of synthetic micro- and nano plastics for method validation studies.
Hrovat B, Uurasjärvi E, Viitala M, Del Pino AF, Mänttäri M, Papamatthaiakis N, Haapala A, Peiponen K, Roussey M, Koistinen A. Hrovat B, et al. Among authors: viitala m. Sci Total Environ. 2024 May 15;925:171821. doi: 10.1016/j.scitotenv.2024.171821. Epub 2024 Mar 19. Sci Total Environ. 2024. PMID: 38513866 Free article.
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients.
Verkkoniemi-Ahola A, Hartikainen P, Hassi K, Kuusisto H, Lahdenperä S, Mehtälä J, Viitala M, Ylisaukko-Oja T, Soilu-Hänninen M. Verkkoniemi-Ahola A, et al. Among authors: viitala m. Mult Scler J Exp Transl Clin. 2023 Oct 4;9(4):20552173231204466. doi: 10.1177/20552173231204466. eCollection 2023 Oct-Dec. Mult Scler J Exp Transl Clin. 2023. PMID: 37808458 Free PMC article.
26 results